Ramez Kouzy

MD Anderson Cancer Center, Houston, TX, United States 
"Ramez Kouzy"


Sign in to add collaborator
Lauren Colbert collaborator
Ethan Ludmir collaborator
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lin D, Alam MBE, Jaoude JA, et al. (2022) Microbiome Dynamics During Chemoradiotherapy for Anal Cancer. International Journal of Radiation Oncology, Biology, Physics
Patel RR, Parisi R, Verma V, et al. (2022) Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14
Colbert LE, Alam MBE, Lynn EJ, et al. (2022) Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16 Cancers. Cancer Immunology Research
Abi Jaoude J, Thunshelle CP, Kouzy R, et al. (2021) Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology. 6: 100763
Corrigan KL, Kry S, Howell RM, et al. (2021) The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology
Abi Jaoude J, Kouzy R, Rooney M, et al. (2021) Impact factor and citation metrics in phase III cancer trials. Oncotarget. 12: 1780-1786
Abi Jaoude J, Kouzy R, Ghabach M, et al. (2021) Food and Drug Administration approvals in phase 3 Cancer clinical trials. Bmc Cancer. 21: 695
Lin D, Moningi S, Abi Jaoude J, et al. (2021) Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal Toxicity. Cancers. 13
Moningi S, Abi Jaoude J, Kouzy R, et al. (2021) Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Advances in Radiation Oncology. 6: 100621
El Alam MB, Sims TT, Kouzy R, et al. (2021) A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. Plos One. 16: e0247905
See more...